IRIS UniCatt

Citterio, Franco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.835
NA - Nord America 5.559
AS - Asia 3.679
SA - Sud America 833
AF - Africa 161
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 10
Totale 25.092
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 10.404
US - Stati Uniti d'America 5.434
SG - Singapore 1.881
DE - Germania 1.102
CN - Cina 890
BR - Brasile 696
NL - Olanda 651
SE - Svezia 651
UA - Ucraina 530
FR - Francia 317
IE - Irlanda 259
GB - Regno Unito 190
VN - Vietnam 179
PL - Polonia 169
ID - Indonesia 164
FI - Finlandia 151
IN - India 146
RU - Federazione Russa 122
TR - Turchia 70
CH - Svizzera 61
CA - Canada 60
JP - Giappone 52
CI - Costa d'Avorio 51
BD - Bangladesh 50
IQ - Iraq 49
BE - Belgio 47
AR - Argentina 44
ES - Italia 42
HK - Hong Kong 42
MX - Messico 37
ZA - Sudafrica 29
IR - Iran 28
MA - Marocco 24
EC - Ecuador 19
AT - Austria 17
CO - Colombia 17
VE - Venezuela 17
CL - Cile 15
CZ - Repubblica Ceca 15
PK - Pakistan 15
KE - Kenya 14
SA - Arabia Saudita 13
AU - Australia 12
BG - Bulgaria 12
RO - Romania 12
EG - Egitto 11
AE - Emirati Arabi Uniti 10
AL - Albania 10
LT - Lituania 9
GR - Grecia 8
IL - Israele 8
JM - Giamaica 8
KR - Corea 8
PH - Filippine 8
TH - Thailandia 8
TN - Tunisia 8
TW - Taiwan 8
UY - Uruguay 8
PT - Portogallo 7
PY - Paraguay 7
DZ - Algeria 6
HU - Ungheria 6
JO - Giordania 6
NP - Nepal 6
SK - Slovacchia (Repubblica Slovacca) 6
AZ - Azerbaigian 5
ET - Etiopia 5
KZ - Kazakistan 5
SI - Slovenia 5
UZ - Uzbekistan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
DK - Danimarca 4
HN - Honduras 4
KG - Kirghizistan 4
MY - Malesia 4
NO - Norvegia 4
PE - Perù 4
RS - Serbia 4
SM - San Marino 4
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
CV - Capo Verde 3
GE - Georgia 3
GT - Guatemala 3
IS - Islanda 3
MD - Moldavia 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PA - Panama 3
A1 - Anonimo 2
BH - Bahrain 2
CR - Costa Rica 2
EU - Europa 2
GY - Guiana 2
MT - Malta 2
NG - Nigeria 2
OM - Oman 2
SO - Somalia 2
UG - Uganda 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 25.069
Salva come PNG Salva come JPEG
Città #
Milan 1.052
Chandler 1.028
Rome 744
Singapore 742
Ashburn 495
Naples 324
Jacksonville 248
San Mateo 246
Dublin 245
Beijing 226
Turin 203
New York 200
Florence 166
Wilmington 163
Jakarta 153
Bologna 142
Palermo 134
Nanjing 129
Ann Arbor 127
Boston 123
Fairfield 111
Bari 104
Los Angeles 102
Lawrence 94
Warsaw 94
Catania 93
Cattolica 93
Genoa 91
Dearborn 79
Verona 71
Redwood City 67
Moscow 66
Houston 63
Ho Chi Minh City 61
Hanoi 59
Brescia 56
Dallas 56
Princeton 54
Seattle 54
Chicago 53
Abidjan 51
São Paulo 51
Kraków 50
Frankfurt am Main 49
Nürnberg 49
Woodbridge 48
Padova 45
Buffalo 44
Hefei 44
Munich 44
Hong Kong 41
Parma 41
Venice 40
Nanchang 39
Bergamo 38
Taranto 37
Brussels 36
Cagliari 36
Guangzhou 36
Redmond 35
Reggio Emilia 35
Mountain View 34
Rio de Janeiro 34
Messina 33
Perugia 33
Pescara 31
Tokyo 30
Boardman 29
Hangzhou 29
Lancaster 29
Livorno 28
San Francisco 28
The Dalles 28
Norwalk 27
Shenyang 27
University Park 27
Izmir 26
Santa Clara 26
Augusta 25
Hebei 25
Helsinki 25
Salerno 25
London 24
Lucca 24
Brooklyn 23
Marseille 23
Modena 23
Monza 23
Bremen 22
Toronto 22
Belo Horizonte 21
Kunming 21
Changsha 20
Novara 20
Rimini 20
Trieste 20
Zhengzhou 20
Leawood 18
Amsterdam 16
Caserta 15
Totale 10.274
Salva come PNG Salva come JPEG
Nome #
Le disfunzioni sessuali maschili in pazienti con insufficienza renale cronica end stage ed in pazienti sottoposti a trapianto renale 11.161
Accidental transplantation of a kidney with stones: case report 178
Emotional self-efficacy and alexithymia may affect compliance, renal function and quality of life in kidney transplant recipients: results from a preliminary cross-sectional study 175
N-Acetylcysteine and High-Dose Atorvastatin Reduce Oxidative Stress in an Ischemia-Reperfusion Model in the Rat Kidney 171
Effects of switching from twice-daily to once-daily tacrolimus formulation on quality of life, anxiety, and transplant benefit perception after kidney transplantation 162
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 161
Increased cancer risk in patients undergoing dialysis: A population-based cohort study in North-Eastern Italy 161
Expanding the living donor pool, "Ist Act": analysis of the causes of exclusion of potential kidney donors. 157
Effects of Switching from Twice-Daily to Once-Daily Tacrolimus Formulation on Quality of Life, Anxiety, and Transplant Benefit Perception after Kidney Transplantation 155
Attachment style predict compliance, quality of life and renal function in adult patients after kidney transplant: preliminary results 155
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 154
Contrast-enhanced Voiding US for Grading of Reflux in Adult Patients Prior to Antireflux Ureteral Implantation1 151
HIGH-DOSE ATORVASTATIN REDUCE OXIDATIVE STRESS OF ISCHEMIA/REPERFUSION INJURY AFTER ISOGENEIC KIDNEY TRANSPLANTATION IN RATS 150
Belatacept utilization recommendations: an expert position 147
Once Daily Everolimus Is Safe and Effective in De Novo Renal Transplant Recipients: Six-Month Results of a Pilot Study. 140
LAPDOCTOR: TELL ME HOW DIFFICULT WILL BE MY DONOR 140
Early Appearance of De Novo Anti-HLA Antibodies Following Renal Transplantation: Preliminary Results of a Prospective Multicenter Study. 136
Late Calcineurin Inhibitors Introduction after Induction with Basiliximab and Thymoglobulin Is Safe and Effective in Old for Old Renal Transplantation: 1-Year Results of a Prospective Clinical Study. 135
Attachment style predict compliance, quality of life and renal function in adult patients after kidney transplant: preliminary results. 130
USE OF A SINGLE DOSE OF BASILIXIMAB AFTER MAJOR SURGICAL PROCEDURES IN KIDNEY TRANSPLANT RECIPIENTS 130
Significant improvement in patient survival after renal transplantation in the last decade. 129
Interventional radiological treatment of renal transplant complications: a pictorial review 128
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 126
Preoperative Psychological Factors Predicting Graft Rejection in Patients Undergoing Kidney Transplant: A Pilot Study 124
CHYLOUS ASCITES AFTER LAPAROSCOPIC LIVING DONOR NEPHRECTOMY. CASE REPORT AND REVIEW OF THE LITERATURE 123
Complete clinical remission of psoriasis 6 months after renal transplantation 121
Metabolic Syndrome and Cardiovascular Disease in Kidney Transplantation 120
COMBINATION OF EXTENDED-RELEASE TACROLIMUS PLUS EVEROLIMUS ONCE-DAILY IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: ER-TAC VERSUS LCPT 120
The reduction of left ventricular hypertrophy after renal transplantation is not influenced by the immunosuppressive regimen. 119
Do patients who participate in a clinic experimental protocol have the same probability of success from that who were not selected or refused to participate? Outcome surveillance, safety, and bioethical considerations in kidney transplant clinical research 118
AN EASY ALGORITHM TO OPTIMIZE THE EXPOSURE TO TACROLIMUS AND EVEROLIMUS, WHEN USED IN COMBINATION 118
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 116
INCIDENCE AND RISK FACTORS FOR DE-NOVO CANCERS IN ITALIAN KIDNEY TRANSPLANT (KT) RECIPIENTS 116
Increase in N-acetyl-beta-glucosaminidase excretion as a marker of kidney damage in cyclosporine-treated renal allografts 115
Summary of the International Conference on Onco-Nephrology: an emerging field in medicine 114
Conversion from Prograf to Advagraf in stable kidney transplant recipients: better renal function after 3-year follow-up 113
Posttransplant encapsulating peritoneal sclerosis, long-term success with everolimus and low-dose CNI: a case report 112
Behavioral and demographic factors associated with occurrence of non-melanoma skin cancer in organ transplant recipients 110
Extended-Release Tacrolimus Plus Everolimus or Micophenolate Mofetil in Deceased Donor Kidney Transplant Recipients: 6-Month Results of a Prospective Randomized Clinical Trial 109
TO TRANSPLANT OR NOT TO TRANSPLANT: A KIDNEY WITH A GIANT CYST. CASE REPORT AND REVIEW OF THE LITERATURE 108
[Nitrogen loss after kidney transplantation: effects of immunosuppressive therapy] 107
RENAL FUNCTION IN PATIENTS TREATED WITH BELATACEPT-OR CYCLOSPORINE-BASED REGIMENS AT YEAR 3 IN THE BENEFIT AND BENEFIT-EXT STUDIES 106
Coenzyme Q. alpha tocopherol graft uptake and lipid peroxidation in human liver transplantation: evidence of energy metabolism protection in University of Wisconsin (UW) solution-preserved livers 106
PRELIMINARY RESULTS FROM A PROSPECTIVE MULTICENTER STUDY REVEAL THE EARLY APPEARANCE OF DE NOVO ANTI-HLA ANTIBODIES FOLLOWING RENAL TRANSPLANTATION 106
Perioperative-, recipient-, and donor-related factors affecting delayed graft function in kidney transplantation 106
Determinants of hemodynamic compensation during veno-venous bypass in liver transplantation 105
Emotional self-efficacy and alexithymia may affect compliance, renal function and quality of life in kidney transplant recipients: Results from a preliminary cross-sectional study 105
Interventional Radiological Treatment of Renal Transplant Complications: A Pictorial Review 105
Living kidney donation from people at risk of nephrolithiasis, with a focus on the genetic forms 105
Living Kidney Donation in a Type 1 Dent's Disease Patient from His Mother 105
Combination of Extended-Release Tacrolimus Plus Everolimus Once Daily in Dc Novo Kidney Transplant Recipients: ER-Tac vs LCPT 105
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 104
Andamento temporale di alcune proteine della fase acuta dopo trapianto di rene 104
How Challenging Will Be My Living Donor? CT Scan and Clinical Evaluation Can Predict Technical Difficulty of Laparoscopic Donor Nephrectomy 102
Anonymity and live-donor transplantation: an ELPAT view 100
Evolution of causes of mortality in renal transplantation in the last 10 years 100
Emotional management and quality of life in mother living versus multi-organ donor renal transplant recipients 100
Increased incidence of cutaneous melanoma in organ transplant recipients based on a single-centre longitudinal study in Rome, Italy. 100
Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience 98
COVID-19 and kidney transplantation: an Italian Survey and Consensus 98
Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial. 97
Nonadherence to immunosuppressive therapy in kidney transplant recipients: can technology help? 96
Spontaneous renal allograft rupture complicated by urinary leakage: case report and review of the literature 95
Inferior Long-Term Outcomes for Kidney Transplant Recipients With an Immunologically Mediated Primary Renal Disease 94
Thymoglobulin and Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplantation: 1-Year Results of a Prospective Clinical Trial 93
Once-a-day administration of everolimus is safe in de novo renal transplant recipients: 1-year results of a pilot study 93
Global Kidney Exchange: opportunity or exploitation? An ELPAT/ESOT appraisal 93
Preoperative psychological factors predicting graft rejection in patients undergoing kidney transplant: a pilot study 92
ONE-SHOT VERSUS MULTIDOSE PERIOPERATIVE ANTIBIOTIC PROPHYLAXIS AFTER KIDNEY TRANSPLANTATION: A RANDOMIZED, CONTROLLED, CLINICAL TRIAL 92
Evaluation of Everolimus Activity against Mycobacterium tuberculosis Using In Vitro Models of Infection 91
Belatacept utilization recommendations: an expert position 91
The Relevance of Directive 2010/53/EU for Living Organ Donation Practice: An ELPAT View 91
Radiofrequency thermal ablation of renal graft neoplasms: A literature review 91
Preoperative psychological factors predicting graft rejection in patients undergoing kidney transplant: a pilot study 90
"Why can't I give you my organs after my heart has stopped beating?" An overview of the main clinical, organisational, ethical and legal issues concerning organ donation after circulatory death in Italy 90
Expanding the living donor pool, "Ist Act": analysis of the causes of exclusion of potential kidney donors 90
Behavioural and demographic factors associated with occurrence of non-melanoma skin cancer in organ transplant recipients 90
Wound Healing Complications and the Use of Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation: A Critical Review of the Literature 89
Once-a-Day Administration of Everolimus Is Safe in De Novo Renal Transplant Recipients: 1-Year Results of a Pilot Study 88
Human humoral immune reactions against pig antigens: a method to clear preexisting preformed natural antibodies 88
Surgical Antibiotic Prophylaxis After Renal Transplantation: Time to Reconsider. 88
Immunosoppressive Therapy and Risk of Post-Transplant Malignancies after Kidney Transplantation: Italian Multicentric Study 87
[Organ transplantation: training and prospects for a young surgeon] 87
Safety of Everolimus With Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplants: An Analysis From the Randomized TRANSFORM Study 87
Isoprinosine effects on postoperative immunodepression 86
Effects of switching from twice-daily to once-daily tacrolimus formulation on quality of life, anxiety, and transplant benefit perception after kidney transplantation 86
Everolimus and Minimization of Cyclosporine in Renal Transplantation: 24-Month Follow-Up of the EVEREST Study 85
Belatacept utilization recommendations: an expert position 85
Dealing With Public Solicitation of Organs From Living Donors--An ELPAT View 85
Re: Complete Clinical Remission of Psoriasis 6 Months After Renal Transplantation Response 84
Everolimus and minimization of cyclosporine in renal transplantation: 24-month follow-up of the EVEREST study 83
Immunosuppression with Belatacept-Based, Corticosteroid-Avoiding Regimens in De Novo Kidney Transplant Recipients 83
De Novo Malignancies after Organ Transplantation: Focus on Viral Infections 83
Prediction, prevention, and management of delayed graft function: where are we now? 83
Pharmacokinetics for once- versus twice-daily tacrolimus formulations in de novo kidney transplantation: a randomized, open-label trial 82
Dealing With Public Solicitation of Organs From Living Donors-An ELPAT View 80
Process control: simply a matter of efficiency or of survival and costs? A single-centre quality improvement project in living donor renal transplant 78
Distinct impact of vitamin D insufficiency on calcitriol levels in chronic renal failure and renal transplant patients: a role for FGF23 78
Cyclosporine levels together with metabolites are more effective than cyclosporine parent compound levels alone in predicting hepatic toxicity after liver transplantation 78
Wound healing complications and the use of mammalian target of rapamycin inhibitors in kidney transplantation: a critical review of the literature 78
Totale 21.975
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.571
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.571
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021639 0 0 0 0 0 100 125 31 152 33 176 22
2021/20221.336 84 125 27 52 46 55 37 227 49 98 267 269
2022/20233.797 332 348 192 452 177 432 152 343 495 203 385 286
2023/20244.961 284 576 300 374 340 488 402 417 349 444 487 500
2024/20257.190 492 664 689 565 691 508 517 589 823 439 662 551
2025/20263.964 1.199 335 492 641 1.191 106 0 0 0 0 0 0
Totale 25.224